Narodowy Instytut LekówResearch institute
Other research and experimental development on natural sciences and engineering
Overview
Narodowy Instytut Leków is a state laboratory involved in the control of medicinal products and medical devices, providing comprehensive quality assessments and microbiological expertise. The institute also conducts scientific research and development tailored to public health needs. Additionally, it offers services related to the sale of laboratory equipment, such as hematological analyzers.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2004-05-26. Active
20 2490 0005 0000 4530 2249 8484
94 1030 1508 0000 0008 1826 0016- 83 1030 1508 0000 0008 1826 0020
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 24, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | — | Prezydent Miasta Stołecznego Warszawy |
European Funds
8 EU budget awards (FTS) recorded, totalling $2,145,615.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-10-01 | 101160053 - Sure-amr - strengthening ukraines research excellence in the field of antimicrobial resistance under a one health approach | $205,337 | 1.0.11 - Horizon Europe | |
| 2024-01-01 | 101127787 - Eu-jamrai 2 - joint action antimicrobial resistance and healthcare-associated infections 2 | $1,199,511 | 2.2.25 - EU4Health | |
| 2022-03-01 | 101046941 - Leadtotreat - targeted nano-formulations for treatment of mrsa: a multicomponent platform for nano-formulated treatment of resistant microbial infections | $361,864 | 1.0.11 - Horizon Europe |
Tenders
8 tenders recorded as contractor: 4 national ($260,824) and 4 EU ($5,218,467), and 52 as contracting authority (43 national and 9 EU).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 13, 2026 | Wykonanie badań jakościowych weterynaryjnych produktów leczniczych | $74,589 | Wojewódzki Inspektorat Weterynarii w Gdańsku | |
| May 11, 2026 | Badania jakościowe produktów leczniczych oraz substancji czynnych w 2026r. | $1,620,746 | Główny Inspektorat Farmaceutyczny | |
| Aug 1, 2025 | Badanie w zakresie oznaczenia jakościowego zawartości niedeklarowanych aktywnych farmakologicznie substancji oraz substancji zakazanych w produkcji środków spożywczych w 90 próbkach suplementów diety | $64,885 | Główny Inspektorat Sanitarny |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Beneficial owners
No beneficial owners recorded for the entity Narodowy Instytut Leków.
Competitors
Selected automatically: mainly by similarity of the business description, plus comparable revenue, industry (PKD code) and location. Only companies with a complete profile (including a logo and financial data) are shown. The list is indicative.
Change history
| Date | Event |
|---|---|
| 2011-07-29 | PKD change (Removed: 22.11.Z, 22.13.Z, 73.10.B, 73.10.D, 73.10.E, 73.10.F, 73.10.H, 75.14.Z, 80.42.B, 85.14.F; Added: 58.11.Z, 58.14.Z, 58.19.Z, 71.20.A, 71.20.B, 72.11.Z, 72.19.Z, 85.59.B, 86.90.E) |
| 2006-12-28 | Name change (Narodowy Instytut Zdrowia Publicznego → Narodowy Instytut Leków) |
| 2005-10-28 | PKD change (Removed: 80.42.Z, 85.14.D; Added: 73.10.E, 80.42.B, 85.14.F) |
| 2002-11-27 | Entered in the register |
FAQ
Last updated: 2026-08-17